New Frontiers in Treating Metastatic Cervical Cancer From Revolutionary Molecules to Clinical Therapies
ESGO eAcademy. Presenters F. 10/23/21; 346489
Ignace Vergote
Christian Marth
Isabelle Ray-Coquard
Mansoor Raza Mirza
Domenica Lorusso
REGULAR CONTENT
About this activity
Discussion Forum (0)
Chair: Ignace Vergote (Belgium)
15:00-15:05 Introduction by Ignace Vergote (Belgium)
15:05-15:20 Perspectives on current treatment landscape for r/m CC by Christian Marth (Austria), Ignace Vergote (Belgium)
15:20-15:35 Experts discuss future treatment modalities for r/m CC byIsabelle Ray-Coquard (France), Mansoor Raza Mirza (Denmark)
15:35-15:50 Can ADCs change r/m CC treatment landscape? by Domenica Lorusso (Italy), Ignace Vergote (Belgium)
15:50-16:00 Live Q&A
Technical Settings:
This live session is available on PC, Tablet and Smartphones. For the best viewing experience, a high-speed internet connection is required. If you have a problem accessing the live webinar, please contact the technical support team at support@multilearning.com.
15:00-15:05 Introduction by Ignace Vergote (Belgium)
15:05-15:20 Perspectives on current treatment landscape for r/m CC by Christian Marth (Austria), Ignace Vergote (Belgium)
15:20-15:35 Experts discuss future treatment modalities for r/m CC byIsabelle Ray-Coquard (France), Mansoor Raza Mirza (Denmark)
15:35-15:50 Can ADCs change r/m CC treatment landscape? by Domenica Lorusso (Italy), Ignace Vergote (Belgium)
15:50-16:00 Live Q&A
Technical Settings:
This live session is available on PC, Tablet and Smartphones. For the best viewing experience, a high-speed internet connection is required. If you have a problem accessing the live webinar, please contact the technical support team at support@multilearning.com.
Code of conduct/disclaimer available in General Terms & Conditions
{{ help_message }}
{{filter}}
